Vanguard Group’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.75M | Buy |
|
|||||
|
2025
Q1 | $1.32M | Buy |
|
|||||
|
2024
Q4 | $459K | Hold |
|
|||||
|
2024
Q3 | $457K | Hold |
|
|||||
|
2024
Q2 | $460K | Hold |
|
|||||
|
2024
Q1 | $454K | Buy |
|
|||||
|
2023
Q4 | $469K | Buy |
|
|||||
|
2023
Q3 | $381K | Buy |
|
|||||
|
2023
Q2 | $445K | Buy |
|
|||||
|
2023
Q1 | $447K | Hold |
|
|||||
|
2022
Q4 | $434K | Buy |
|
|||||
|
2022
Q3 | $489K | Buy |
|
|||||
|
2022
Q2 | $649K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Buy |
|
|||||
|
2021
Q4 | $1.34M | Buy |
|